R. Kase et al., Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease, BBA-MOL BAS, 1501(2-3), 2000, pp. 227-235
Citations number
33
Categorie Soggetti
Medical Research General Topics
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
The mutant products Q279E ((279)Gln to Glu) and R301Q ((301)Arg to Gin) of
the X-chromosomal inherited alpha-galactosidase (EC 3.2.1.22) gene, found i
n unrelated male patients with variant Fabry disease (late-onset cardiac fo
rm) were characterized. In contrast to patients with classic Fabry disease,
who have no detectable alpha-galactosidase activity, atypical variants hav
e residual enzyme activity. First, the properties of insect cell-derived re
combinant enzymes were studied. The K-m and y(max) values of Q279E, R301Q,
and wild-type alpha-galactosidase toward an artificial substrate, 4-methylu
mbelliferyl-alpha-D-galactopyranoside, were almost the same. In order to mi
mic intralysosomal conditions, the degradation of the natural substrate, gl
obotriaosylceramide, by the alpha-galactosidases was analyzed in a detergen
t-free-liposomal system, in the presence of sphingolipid activator protein
B (SAP-B, saposin B). Kinetic analysis revealed that there was no differenc
e in the degradative activity between the mutants and wild-type alpha-galac
tosidase activity toward the natural substrate. Then, immunotitration studi
es were carried out to determine the amounts of the mutant gene products na
turally occurring in cells. Cultured lymphoblasts, L-57 (Q279E) and L-148 (
R301Q), from patients with variant Fabry disease, and L-20 (wild-type) from
a normal subject were used. The 50% precipitation doses were 7% (L-57) and
10% (L-148) of that for normal lymphoblast L-20, respectively. The residua
l alpha-galactosidase activity was 3 and 5% of the normal level in L-57 and
L-148, respectively. The quantities of immune cross-reacting materials rou
ghly correlated with the residual alpha-galactosidase activities in lymphob
last cells from the patients. Compared to normal control cells, fibroblast
cells from a patient with variant Fabry disease, Q279E mutation, secreted o
nly small amounts of alpha-galactosidase activity even in the presence of 1
0 mM NH4Cl. It is concluded that Q279E and R301Q substitutions do not signi
ficantly affect the enzymatic activity, but the mutant protein levels are d
ecreased presumably in the ER of the cells. (C) 2000 Elsevier Science B.V.
All rights reserved.